The American Society of Human Genetics (ASHG) is deeply concerned by the Executive Order (EO) issued last week titled “Improving Oversight of Federal Grantmaking.” While ASHG supports efforts to ensure transparency, accountability, and scientific rigor in federally funded research, we are particularly troubled that the EO’s directives risk introducing political considerations into the grantmaking process.... Read More
The Society’s proposed language on diversity in research participation has been incorporated in the final version of this year’s Senate NIH funding bill. The proposed text included in the bill is below: The Committee recognizes the benefits of broad and inclusive participation in biomedical research for increasing health equity. Research cohorts of diverse genetic ancestry... Read More
While summer in Washington D.C. is usually a quiet time – both the U.S. Senate and the House of Representatives traditionally break for a recess for most of the month of August – this year is looking to be the exception. Congress is having a busier summer than usual as legislation for politically charged issues... Read More
A new report commissioned by ASHG examines how human genetics and genomics is growing the U.S. economy and becoming increasingly integrated in healthcare and society. The new report, titled “The Economic Impact and Functional Applications of Human Genetics and Genomics,” indicates that the human genetics and genomics sector contributes $265 billion to the U.S. economy... Read More